AnaptysBio, Inc.
ANAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15,113 | -$38,630 | -$39,329 | -$21,784 |
| Dep. & Amort. | $610 | $601 | $606 | $601 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,239 | $9,170 | $8,184 |
| Change in WC | -$73,621 | -$29,463 | $2,459 | -$68,775 |
| Other Non-Cash | $30,542 | $18,009 | $16,394 | $15,102 |
| Operating Cash Flow | -$27,356 | -$40,244 | -$10,700 | -$66,672 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$39 | -$35 | -$263 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$19,656 | -$54,208 | -$122,547 | -$120,882 |
| Inv. Sales/Matur. | $122,950 | $90,650 | $137,429 | $91,749 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $103,282 | $36,403 | $14,847 | -$29,396 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,007 | -$823 | $0 | $0 |
| Stock Issued | $336 | $1,423 | $290 | $555 |
| Stock Repurch. | -$9,720 | -$51,098 | -$4,424 | -$456 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$24,456 | $27,468 |
| Financing Cash Flow | -$10,391 | -$50,498 | -$28,590 | $27,567 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $65,535 | -$54,339 | -$24,443 | -$68,501 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,298 | $98,637 | $123,080 | $191,581 |
| End Cash | $109,833 | $44,298 | $98,637 | $123,080 |
| Free Cash Flow | -$27,368 | -$40,283 | -$10,735 | -$66,935 |